Related Compounds
Compounds connected by the same goals, effects, or research topics.
Compound Profile
Uc Ii Collagen carries a Grade B rating — moderate evidence.
Use extra caution — Review medications, pregnancy status, chronic conditions, and clinician guidance before use. Details
Continue reading
Safety
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Safety outcomes did not differ from placebo or glucosamine-chondroitin, but product-source allergy, pregnancy, breastfeeding, autoimmune disease, longer-term use, organ impairment, and medication-interaction safety remain insufficient.
Useful signal, but study design, dose, and population still matter.
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Immune Signaling Modulation · Oral Tolerance Induction · Th2/Treg Skewing (Proposed)
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.
This profile cites 2 human studies.
Confidence estimate based on the design quality and consistency of published clinical trials.
Uc II Collagen has a moderate evidence rating.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
What the evidence actually shows
This table contains 2 structured sources, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.
Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned
What would change our conclusion?
Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Effects of Native Type II Collagen Treatment on Knee Osteoarthritis: A Randomized Controlled Trial PubMed · Eurasian J Med · 2016 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
PubMed · J Int Soc Sports Nutr · 2013 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Uc II Collagen Works
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Condition guides
Continue exploring
Compounds connected by the same goals, effects, or research topics.
Botanicals connected by the same goals, effects, or research topics.
Deeper context, comparisons, and practical research paths.
Safety checks and cautions relevant to this decision.
Deeper context, comparisons, and practical research paths.
Compare side-by-side tradeoffs or verify active marker guidelines.
Free safety checklist
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Compound profile context
Uc II Collagen compound profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Uc II Collagen, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.